Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097970 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von David Á Karádi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary. Hauptthemen laut MEDLINE: Analgesics, Opioid, Neuralgia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: new national excellence program of the ministry for culture and innovation from the source of the national research, development and innovation fund, Semmelweis 250+ Kiválósági PhD Ösztöndíj, Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Neurology Thematic Programme of….
Abstract (Originalsprache)
Despite the large arsenal of analgesic medications, neuropathic pain (NP) management is not solved yet. Angiotensin II receptor type 1 (AT1) has been identified as a potential target in NP therapy. Here, we investigate the antiallodynic effect of AT1 blockers telmisartan and losartan, and particularly their combination with morphine on rat mononeuropathic pain following acute or chronic oral administration. The impact of telmisartan on morphine analgesic tolerance was also assessed using the rat tail-flick assay. Morphine potency and efficacy in spinal cord samples of treated neuropathic animals were assessed by [35S]GTPγS-binding assay. Finally, the glutamate content of the cerebrospinal fluid (CSF) was measured by capillary electrophoresis. Oral telmisartan or losartan in higher doses showed an acute antiallodynic effect. In the chronic treatment study, the combination of subanalgesic doses of telmisartan and morphine ameliorated allodynia and resulted in a leftward shift in the dose–response curve of morphine in the [35S]GTPγS binding assay and increased CSF glutamate content. Telmisartan delayed morphine analgesic-tolerance development. Our study has identified a promising combination therapy composed of telmisartan and morphine for NP and opioid tolerance. Since telmisartan is an inhibitor of AT1 and activator of PPAR-γ, future studies are needed to analyze the effect of each component.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.
- Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.
- Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, 9700 AD Groningen, The Netherlands.
- Biological Research Center, Institute of Biochemistry, Temesvári krt. 62, H-6726 Szeged, Hungary.
ORCID-Profile: David Á Karádi, Kornél Király, Pál Riba, Edina Szűcs, Sándor Benyhe, Zoltán V Varga, Éva Szökő, Tamás Tábi, Mahmoud Al-Khrasani
Förderung
- new national excellence program of the ministry for culture and innovation from the source of the national research, development and innovation fund
- Semmelweis 250+ Kiválósági PhD Ösztöndíj
- Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Neurology Thematic Programme of…
- Ministry for Culture and Innovation
- Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary
Zitieren
APA
Karádi, D. Á., Galambos, A. R., Lakatos, P. P., Apenberg, J., Abbood, S. K., Balogh, M., Király, K., Riba, P., Essmat, N., Szűcs, E., Benyhe, S., Varga, Z. V., Szökő, É., Tábi, T., & Al-Khrasani, M. (2023). Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097970
Vancouver
Karádi DÁ, Galambos AR, Lakatos PP, Apenberg J, Abbood SK, Balogh M, et al. Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097970
BibTeX
@article{Kardi2023,
author = {Karádi, David Á and Galambos, Anna Rita and Lakatos, Péter P and Apenberg, Joost and Abbood, Sarah K and Balogh, Mihály and Király, Kornél and Riba, Pál and Essmat, Nariman and Szűcs, Edina and Benyhe, Sándor and Varga, Zoltán V and Szökő, Éva and Tábi, Tamás and Al-Khrasani, Mahmoud},
title = {Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097970}
}
EUVIMED